Serum levels of early-glycated albumin are significantly increased in patients with diabetes
mellitus and may play a role in worsening inflammatory status and sustaining diabetes …

Abstract The Advanced Glycation and Lipoxidation End products (AGEs and ALEs) are a
heterogeneous class of compounds derived from the non-enzymatic glycation or protein …

Aims/hypothesis Activation of the receptor for advanced glycation end products (RAGE)
reportedly triggers cellular responses implicated in the pathogenesis of diabetes, such as …

Albumin, a major plasma protein with extraordinary ligand binding properties, transports
various ligands ranging from drugs, hormones, fatty acids, and toxins to different tissues and …

BACKGROUND: Serum protein glycation and formation of advanced glycation endproducts
(AGE) correlates with diabetic complications. Highly AGE-modified albumin is frequently …

Albumin, the major circulating protein in blood, can undergo increased glycation in diabetes.
One of the main properties of this plasma protein is its strong affinity to bind many …

In vivo modification of proteins by molecules with reactive carbonyl groups leads to
intermediate and advanced glycation end products (AGE). Glucose is a significant glycation …

Diabetes is defined by chronic hyperglycemia due to deficiency in insulin action. It has been
found that the amount of advanced glycation end products (AGE) from the Maillard reaction …

Background Albumin glycation and subsequent formation of advanced glycation end
products (AGEs) correlate with diabetes and associated complications. Methods Human …

The receptor for advanced glycation end products (RAGE) is a multi-ligand receptor involved
in the development of diabetic complications. Using an Escherichia coli expression system …